… development as novel colon cancer chemopreventive drugs. We provide further new perspectives
from this old research, … Drug development against KRAS, BRAF or PIK3CA mutations …

… cancer chemoprevention as a mean to reduce global cancer … or delaying the development
of cancer using drugs or … between cancer chemoprevention and cancer prevention is that the …

… of cancer risk, we here call for personalized approaches for cancer prevention and …
preventive and interceptive strategies to reduce cancer burden. Investment into translational …

… of reducing cancer incidences. In this review, we will summarize the current status of cancer
prevention, focusing on the major agents that are clinically used for chemoprevention and …

… a tremendous impact on drug discovery endeavours, receiving US Food and Drug
Administration (FDA) approval, and are gaining increasing attention for chemoprevention as well as …

… drug development, the testing of potential chemopreventive agents proceeds through many
phases of studies … in the past to assess the chemopreventive efficacy of compounds on the …

… Cancer chemoprevention Cancer chemoprevention can be explained as use of multiple
intervention strategies by natural or synthetic agents to reverse, suppress or prevent the …

… has certainly proven its potential to deliver the drugs in more effective, safer, and … research
in this area is further advancing towards development of nanovaccines for cancer prevention. …

… There are also ongoing trials evaluating repurposed drugs to be used in breast cancer
prevention. The PROMISE study is a multi-institution window trial randomizing postmenopausal …

… One of the important tasks in the development of cancer chemoprevention is the establishment
of a valid surrogate endpoint. Although the incidence of cancer itself is the most reliable …